Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
SB

WKN: A42QPW | ISIN: US8677818820 | Ticker:
NASDAQ
18.11.26 | 21:56
2,410 US-Dollar
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
SUNSHINE BIOPHARMA INC Chart 1 Jahr
5-Tage-Chart
SUNSHINE BIOPHARMA INC 5-Tage-Chart

Aktuelle News zur SUNSHINE BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiSunshine Biopharma Inc. - S-1, General form for registration of securities-
12.11.Sunshine Biopharma Inc. - 10-Q, Quarterly Report9
22.10.Sunshine Biopharma Inc.: Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing304FORT LAUDERDALE, FL / ACCESS Newswire / October 22, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company specializing in generic and specialty prescription medications...
► Artikel lesen
09.10.Sunshine Biopharma Inc. - 8-K, Current Report8
09.10.Sunshine Biopharma schließt Kapitalerhöhung über 6 Millionen US-Dollar ab2
09.10.Sunshine Biopharma Inc.: Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering471$6.0 million upfront with an additional $14.4 million of potential aggregate gross proceeds upon the exercise of warrants FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2026 / Sunshine Biopharma...
► Artikel lesen
08.10.Sunshine Biopharma announces pricing of $6M public offering3
SUNSHINE BIOPHARMA Aktie jetzt für 0€ handeln
08.10.Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering365FORT LAUDERDALE, FL / ACCESS Newswire / October 8, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company specializing in generic and specialty prescription medications...
► Artikel lesen
02.10.Sunshine Biopharma Inc. - S-1, General form for registration of securities6
24.09.Sunshine Biopharma Launches Generic Ondansetron Tablets In Canada4
24.09.Sunshine Biopharma launches generic ondansetron in Canada3
24.09.Sunshine Biopharma Inc.: Sunshine Biopharma Launches Generic Zofran in Canada, Expanding Oncology Supportive Care Portfolio328Launch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with chemotherapy, radiation therapy and surgeryGlobal ondansetron market projected to reach $2.98 billion by 2034...
► Artikel lesen
16.09.Sunshine Biopharma Inc.: Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies473Nanomolar potency against PLpro with broad-spectrum SARS-CoV-2 variants activitySignificant dose-dependent suppression of pulmonary viral replication in vivoStrong oral bioavailability and preferential...
► Artikel lesen
16.09.EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies4
11.09.Sunshine Biopharma senkt Ausübungspreis für Serie-B-Optionsscheine8
11.09.Sunshine Biopharma Inc. - 8-K, Current Report1
31.08.Sunshine Biopharma erhält kanadische Zulassung für Atenolol-Tabletten5
31.08.Sunshine Biopharma receives Canadian approval for atenolol tablets2
31.08.Sunshine Biopharma Inc.: Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions395FORT LAUDERDALE, FL / ACCESS Newswire / August 31, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications...
► Artikel lesen
26.08.Sunshine Biopharma reports progress on K1.1 mRNA cancer program5
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1